Veronica L.
- Country
- Italy
- Department
- SC Pediatria
Research Overview
- Safety and Efficacy of Asciminib, Blinatumomab, and Combination Therapy in Pediatric and Young Adult Patients with Relapsed/Refractory BCR::ABL1+ or Ph-like ALL
- Evaluation of Ponatinib in Pediatric Patients with Recurrent or Refractory Leukemias, Lymphomas, and Solid Tumors: A Phase 1/2 Open-Label Study
- Phase 2 Randomized Study of Inotuzumab Ozogamicin Monotherapy Versus ALLR3 Regimen in Pediatric High-Risk First Relapse CD22-Positive B-Cell Precursor Acute Lymphoblastic Leukemia
Data & Insights
Has run more than one trial at 71 of 169 partner sites.
Specializations
Pediatric Hematologic Oncology
The investigator specializes in treating childhood acute lymphoblastic leukemia (ALL), with particular focus on high-risk B-cell precursor ALL and innovative therapeutic approaches for young patients aged 1-18 years.
- CD22-positive B-cell precursor ALL treatment
- Bone marrow relapse management
- Novel monotherapy approaches
Expertise includes targeted therapies utilizing Inotuzumab Ozogamicin for pediatric leukemia treatment.
Advanced Cancer Therapeutics
The investigator focuses on developing treatments for recurrent and refractory malignancies in pediatric patients, including both hematologic cancers and solid tumors.
- Chronic Myeloid Leukemia (CML) treatment
- Tyrosine kinase inhibitor therapy
- T315I mutation targeted treatment
Specializes in advanced hematologic malignancies and resistance management in pediatric cancer cases.
Precision Medicine Applications
The investigator works with targeted therapeutic approaches for pediatric cancer treatment, particularly focusing on patients with specific genetic markers and mutations.
- BCR-ABL targeted therapy
- Drug resistance management
- Dose optimization strategies
Expertise in personalized treatment approaches for complex pediatric cancer cases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.